Search Within

CTCR Scholars

Formats
  1. Meeting Abstract (873)
  2. Journal Article (564)
  3. Review (72)
  4. Research Letter (38)
  5. Editorial (29)
  6. Correspondence (24)
  7. Miscellaneous (17)
  8. Book Section (11)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. Department of Medicine (1415)
  2. Hematologic Malignancies, Division of (1082)
  3. MSK Grad Students (1018)
  4. Center for Hematologic Malignancies (985)
  5. Master of Science in Clinical and Translational Cancer Research (983)
  6. Survivorship Research (917)

More Groups

People
  1. Sergio Giralt (553)
  2. Miguel-Angel Perales (411)
  3. Michael Scordo (385)
  4. Gunjan Shah (341)
  5. Sean Devlin (333)
  6. Parastoo Dahi (305)

More People

Years
  1. 2025 (98)
  2. 2024 (251)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (318)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (144)
  4. Annals of Surgical Oncology (83)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (56)

More Publications

Publishers
  1. Elsevier Inc. (390)
  2. American Society of Hematology (372)
  3. American Society of Clinical Oncology (158)
  4. Nature Publishing Group (134)
  5. Springer (102)
  6. American Association for Cancer Research (65)

More Publishers

Results (1639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The complex structural variant chromothripsis can be defined on targeted sequencing panels, allowing direct clinical translation in order to improve multiple myeloma prognostication
    Meeting Abstract

    Maclachlan, K. H.; Ziccheddu, B.; Tan, C.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Diamond, B.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Successful incorporation of electronic patient reported outcomes using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy
    Meeting Abstract

    Shah, G. L.; Lobaugh, S.; Sukhu, R.; Devlin, S. M.; Atkinson, T.; Kemeny, E.; Stetson, P.; Perales, M. A.; Giralt, S. A.; Scordo, M.
    Blood (2023)

    Fulltext@MSK | Save
  • Cumulative incidence of myeloid neoplasms in patients with nodal T-follicular helper cell lymphoma
    Meeting Abstract

    Stuver, R.; Ganesan, N.; Dogan, A.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Lewis, N.; Moskowitz, A.; Shah, G. L.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Identifying causes of unscheduled healthcare interactions and changes to patient disposition in individuals receiving outpatient commercial bispecific antibody therapy in relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Howard, A. J.; Shekarkhand, T.; Hamadeh, I. S.; Wang, A.; Patel, D.; Tan, C.; Hultcrantz, M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world outcomes in patients with transformed follicular lymphoma treated with CD19-targeting CAR-T therapy
    Meeting Abstract

    Rivas-Delgado, A.; Luttwak, E.; Drill, E.; Goldstein, I.; Landego, I.; Tomas, A. A.; Parascondola, A.; Saldia, A.; Caron, P.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves quality of life, metabolic, microbiome and immune profile in MGUS/SMM as well as progression trajectory in a subset - the Nutrivention trial
    Meeting Abstract

    Shah, U. A.; Castro, F.; Derkach, A.; Fei, T.; Hosszu, K. K.; McAvoy, D.; DeWolf, S.; Cross, J.; Gradissimo, A.; Nwankwo, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The composite health risk assessment model (CHARM) to predict 1-year non-relapse mortality (NRM) among older recipients of allogeneic transplantation: A prospective BMT-CTN study 1704
    Meeting Abstract

    Artz, A.; Logan, B. R.; Saber, W.; Geller, N.; Bellach, A.; Kou, J.; Wood, W.; McCarty, J. M.; Knight, T. G.; Runaas, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patient-reported outcomes in the phase 3 CARTITUDE-4 study of ciltacabtagene autoleucel vs standard of care in patients with lenalidomide-refractory multiple myeloma after 1-3 lines of therapy
    Meeting Abstract

    Mina, R.; Mylin, A. K.; Yokoyama, H.; Magen, H.; Alsdorf, W.; Minnema, M. C.; Shune, L.; Isufi, I.; Harrison, S. J.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Trem-cel, a CRISPR/Cas9 gene-edited allograft lacking CD33, shows rapid primary engraftment with CD33-negative hematopoiesis in patients with high-risk acute myeloid leukemia (AML) and avoids hematopoietic toxicity during gemtuzumab ozogamicin (GO) maintenance post-hematopoietic cell transplant (HCT)
    Meeting Abstract

    DiPersio, J.; Cooper, B. W.; Suh, H. C.; Koura, D.; Bernard, L.; Shah, N. N.; Walter, R. B.; Perales, M. A.; Mapara, M.; Tamari, R.; more...
    Blood (2023)

    Fulltext@MSK | Save